GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mangalam Drugs & Organics Ltd (BOM:532637) » Definitions » Debt-to-Asset

Mangalam Drugs & Organics (BOM:532637) Debt-to-Asset : 0.00 (As of Jun. 2024)


View and export this data going back to 2005. Start your Free Trial

What is Mangalam Drugs & Organics Debt-to-Asset?

Mangalam Drugs & Organics's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2024 was ₹0 Mil. Mangalam Drugs & Organics's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2024 was ₹0 Mil. Mangalam Drugs & Organics's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Jun. 2024 was ₹0 Mil.


Mangalam Drugs & Organics Debt-to-Asset Historical Data

The historical data trend for Mangalam Drugs & Organics's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mangalam Drugs & Organics Debt-to-Asset Chart

Mangalam Drugs & Organics Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Debt-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.23 0.26 0.27 0.25 0.32

Mangalam Drugs & Organics Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.23 - 0.32 -

Competitive Comparison of Mangalam Drugs & Organics's Debt-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Mangalam Drugs & Organics's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mangalam Drugs & Organics's Debt-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mangalam Drugs & Organics's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Mangalam Drugs & Organics's Debt-to-Asset falls into.



Mangalam Drugs & Organics Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Mangalam Drugs & Organics's Debt-to-Asset for the fiscal year that ended in Mar. 2024 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(885.034 + 184.879) / 3337
=0.32

Mangalam Drugs & Organics's Debt-to-Asset for the quarter that ended in Jun. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Mangalam Drugs & Organics  (BOM:532637) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.


Mangalam Drugs & Organics Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Mangalam Drugs & Organics's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Mangalam Drugs & Organics Business Description

Traded in Other Exchanges
Address
P. D\'Mello Road, Rupam Building, 3rd Floor, No. 239, Near General Post Office, Mumbai, MH, IND, 400001
Mangalam Drugs & Organics Ltd is an Indian company operating in the healthcare sector. The company is engaged in the research and development and manufacturing of drugs. Its product range includes Active Pharmaceutical Ingredients (APIs), Intermediates, and Specialty chemicals. Its sales comprise sales in the Indian and overseas markets. The single operating segment of the company is the Manufacturing of Bulk Drugs.

Mangalam Drugs & Organics Headlines

No Headlines